Toxic epidermal necrolysis (TEN) associated with the use of nivolumab (PD-1 inhibitor) for lymphoma
Main Authors: | Liezel L. Griffin, MBBS, Laura Cove-Smith, PhD, Hana Alachkar, MD, John A. Radford, MD, Rebecca Brooke, MD, Kim M. Linton, PhD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-04-01
|
Series: | JAAD Case Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352512617302370 |
Similar Items
-
Acute generalized exanthematous pustulosis simulating Stevens-Johnson syndrome/toxic epidermal necrolysis associated with the use of vismodegib
by: Oscar M. Moreno-Arrones, MD, et al.
Published: (2018-03-01) -
Amniotic membrane transplantation in a 2-month-old infant with toxic epidermal necrolysis
by: Abdelrahman M. Elhusseiny, MD, et al.
Published: (2021-03-01) -
Toxic epidermal necrolysis associated with nivolumab treatment for head and neck cancer
by: Keiichi Koshizuka, et al.
Published: (2021-02-01) -
Stevens-Johnson syndrome and toxic epidermal necrolysis in pregnant patients: A systematic review
by: Ajay N. Sharma, BS, et al.
Published: (2020-09-01) -
The Role of IL-13, IL-15 and Granulysin in the Pathogenesis of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis
by: Michael Sadek MD, et al.
Published: (2021-02-01)